Clinical Trial
Study Details
Enrollment
18
Interventions
Description
Administered orally
Name
Prasugrel (clinical formulation)
Type
Drug
Description
Administered orally
Name
Prasugrel (Orally Disintegrating Tablet [ODT])
Type
Drug
Phase
Phase 1
Status
COMPLETED
Study ID #
NCT01430091
Study Type
Interventional
Summary
This study compares the clinical tablet formulation of prasugrel taken orally with an orally disintegrating tablet (ODT) taken orally. The study will evaluate the amount of prasugrel active metabolite circulating in the blood for each treatment.
Study Overview
Conditions
Contacts and Locations
Locations
Facility
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Honolulu, Hawaii
United States
GeoPoint
21.30694, -157.85833